Poland· PL-100103139
Zofran Zydis
A ondansetron product containing ondansetronum, registered in Poland by Sandoz GmbH. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ondansetron is registered in 19 of 19 countries.
Countries holding a registration under ATC A04AA01 (ondansetron), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Ondansetron · ATC A04AA01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ondansetron costs, country by country.
Normalised to the WHO defined daily dose (16 mg), the median price runs from $0.23 in United States to $18.43 in Switzerland — a ×79 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ondansetron · price per daily dose (16 mg)
USD · FX 28 Sept 2026
- CH Switzerland$18.43
- IT Italy$14.68
- FR France$5.36
- US United States$0.23 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Ondansetronum
- Manufacturer
- Sandoz GmbH
- Country
- Poland (PL)
- ATC code
- A04AA01
- ATC class
- Ondansetron
- Defined daily dose
- 16 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- gtin0590999088801610 szt.PLN 45.44
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
841 interactions on record for ondansetron.
Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ondansetron · interactions on record
841 records
- 139 severe
- 240 moderate
- 6 minor
- 402 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- FenfluramineA08AA02severe
54 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ondansetron in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAmetron Melt 8mg oral lyophilisatesTriOn Pharma Ltd
- BelgiumZofran-Zydis 8 mgSandoz
- SpainZOFRAN ZYDIS 8 mg LIOFILIZADO ORALBexal Farmaceutica S.A.
- FranceZOPHREN 8 mg, lyophilisat oralSANDOZ
- IrelandZofran Zydis 8 mg oral lyophilisateRowex Limited,
- United StatesondansetronSagent Pharmaceuticals
- CzechiaNOVETRONPHARMAGEN CZ s.r.o., Praha
- FinlandEmeondanAlfred E.Tiefenbacher GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ondansan, Ondansan I.V.
- Belgium · Ondansetron Ab, Ondansetron Accord Healthcare
- Bulgaria · Zofran, Зондарон
- Cyprus · Ondansetron Accord, Ondansetron Noridem
- Czechia · Novetron, Ondansetron Accord
- Germany · Cellondan, Ondansetron 1 A Pharma
- Denmark · Ondansetron "kalceks", Ondansetron "stada"
- Estonia · Ondansetron Accord, Ondansetron Basi
- Spain · Ondansetrón Accord, Ondansetron Aristo
- Finland · Ondansetron Accord, Ondansetron Accordpharma
- France · Ondansetron Accord, Ondansetron Arrow
- United Kingdom (Northern Ireland) · Ametron Melt, Emistem
- Greece · Cruzafen, Odasen
- Croatia · Ondansetron Kalceks, Ondanzetron Kabi
- Hungary · Emetron, Ondansetron Kabi
- Ireland · Emizof, Ondansetron Accord Healthcare Ireland
- Iceland · Cinveron, Ondansetron Bluefish
- Italy · Emistop, Ondansetron Accord
- Lithuania · Ondansetron Accord, Ondansetron Basi
- Luxembourg · Avessaron, Ondansetron B. Braun
- Latvia · Emetron, Ondansetron Accord
- Malta · Emytron, Ondansetron Accord Healthcare Ireland
- Netherlands · Ondansetron Accord, Ondansetron Aspire
- Norway · Ondansetron Accord, Ondansetron Accordpharma
- Portugal · Danevon, Emytron
- Romania · Ondansetron Aurobindo, Ondansetron Kabi
- Sweden · Ondansetron Accord, Ondansetron Accordpharma
- Slovenia · Ondansetron Accord, Ondansetron Baxter
- Slovakia · Ondansetron Accord, Ondansetron B. Braun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7158a9c4-6f3a-42f1-bc28-66bc6307cbbe GET /v1/drugs/7158a9c4-6f3a-42f1-bc28-66bc6307cbbe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Liofilizat doustny",
"source": "urpl",
"strength": "8 mg",
"packaging": "05909990888016 ¦ Rp ¦ 17828\n10 szt.",
"substance": "Ondansetronum 8 mg",
"common_name": "Ondansetronum",
"pl_product_id": "100103139",
"pozwolenie_nr": "08880",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about ondansetron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.